REQUEST A DEMO
Total
USD $0.00
Search more companies

Teva Baltics UAB (Lithuania)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Teva Baltics UAB Profile Updated: May 20, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Russian Download a sample report

Teva Baltics UAB is based in Lithuania, with the head office in Vilnius. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on February 22, 1999. 101 - 200 (2021) employees currently work for Teva Baltics UAB. In its most recent financial highlights, the company reported a net sales revenue increase of 4.67% in 2020. During that time, Teva Baltics UAB’s total assets decreased by 56.72%. In 2020, Teva Baltics UAB’s net profit margin increased by 2.08%.

Headquarters
Moletu pl. 5
Vilnius; Vilnius county;

Contact Details: Purchase the Teva Baltics UAB report to view the information.

Basic Information
Total Employees:
Purchase the Teva Baltics UAB report to view the information.
Outstanding Shares:
Purchase the Teva Baltics UAB report to view the information.
Registered Capital:
Purchase the Teva Baltics UAB report to view the information.
Incorporation Date:
February 22, 1999
Key Executives
Purchase this report to view the information.
General Director
Subsidiaries
Uab Teva Baltics Filiale Latvija (Latvia)
Company Performance
Financial values in the chart are available after Teva Baltics UAB report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
4.67%
Total operating revenue
4.73%
Operating profit (EBIT)
25.69%
Net Profit (Loss) for the Period
12.01%
Total assets
-56.72%
Total equity
-59.52%
Operating Profit Margin (ROS)
6.21%
Net Profit Margin
2.08%
Return on Equity (ROE)
19.76%
Quick Ratio
-5.41%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?